BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci. 2015;17:14. [PMID: 26712744 DOI: 10.3390/ijms17010014] [Cited by in Crossref: 256] [Cited by in F6Publishing: 198] [Article Influence: 42.7] [Reference Citation Analysis]
Number Citing Articles
1 Singh AK, Verma S, Kumar-M P, Soni H, Sharma S, Patil A, Sharma V. Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis.Expert Rev Clin Pharmacol. 2020;13:1253-1262. [PMID: 33043729 DOI: 10.1080/17512433.2020.1835468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vidal-Cevallos P, Higuera-De-La-Tijera F, Chávez-Tapia NC, Sanchez-Giron F, Cerda-Reyes E, Rosales-Salyano VH, Servin-Caamaño A, Vázquez-Medina MU, Méndez-Sánchez N. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Ann Hepatol 2021;24:100338. [PMID: 33647501 DOI: 10.1016/j.aohep.2021.100338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S, Patwardhan M, Tyler H, Raheja R, Stanley AM, Pineda-Salgado L, Bourdet DL, Andrade RJ, Hayashi PH, Dimick-Santos L, Rockey DC, Estilo A. Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Saf 2021;44:619-34. [PMID: 33725335 DOI: 10.1007/s40264-021-01051-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kesenogile B, Godman B, Rwegerera GM. Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana. Expert Rev Anti Infect Ther 2021;19:379-91. [PMID: 32909487 DOI: 10.1080/14787210.2020.1822735] [Reference Citation Analysis]
5 Mahomoodally F, Suroowan S, Sreekeessoon U. Adverse reactions of herbal medicine—A quantitative assessment of severity in Mauritius. Journal of Herbal Medicine 2018;12:49-65. [DOI: 10.1016/j.hermed.2018.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
6 Xie C, Abdullah HMA, Abdallah M, Quist E, Niazi M. Anastrozole-induced liver injury after a prolonged latency: a very rare complication of a commonly prescribed medication. BMJ Case Rep 2019;12:e231741. [PMID: 31780604 DOI: 10.1136/bcr-2019-231741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 López-Riera M, Conde I, Castell JV, Jover R. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients. Toxicol Sci 2020;173:229-43. [PMID: 31198949 DOI: 10.1093/toxsci/kfz138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Teschke R, Danan G. Causality Assessment Methods in Drug-Induced Liver Injury. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 555-94. [DOI: 10.1007/978-1-4939-7677-5_27] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
9 Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39:1906-17. [PMID: 31319011 DOI: 10.1111/liv.14195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
10 Ruperti-Repilado FJ, Haefliger S, Rehm S, Zweier M, Rentsch KM, Blum J, Jetter A, Heim M, Leuppi-Taegtmeyer A, Terracciano L, Bernsmeier C. Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to Artemisia annua Tea. Front Med (Lausanne) 2019;6:221. [PMID: 31681778 DOI: 10.3389/fmed.2019.00221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Jing J, Wang RL, Zhao XY, Zhu Y, Niu M, Wang LF, Song XA, He TT, Sun YQ, Xu WT, Yu SM, Wang LP, Guo YM, Bai ZF, Xiao XH, Wang JB. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China. BMJ Open. 2019;9:e023567. [PMID: 30782709 DOI: 10.1136/bmjopen-2018-023567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
12 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
13 Zeng B, Yuan L, Chu J, Yang Y, Lin S. Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review. J Int Med Res 2020;48:300060519891018. [PMID: 31840543 DOI: 10.1177/0300060519891018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Yamazaki S, Suzuki T, Sayama M, Nakada TA, Igari H, Ishii I. Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19. J Infect Chemother 2021;27:390-2. [PMID: 33402301 DOI: 10.1016/j.jiac.2020.12.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Yang M, Li Z, Dou D. Can Retrospective Studies Confirm Causes of Drug-Induced Liver Injury? Gastroenterology 2019;157:1436-7. [PMID: 31442432 DOI: 10.1053/j.gastro.2019.03.078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Meunier L, Larrey D. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation. Front Pharmacol 2019;10:1482. [PMID: 31920666 DOI: 10.3389/fphar.2019.01482] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
17 Lüde S, Vecchio S, Sinno-Tellier S, Dopter A, Mustonen H, Vucinic S, Jonsson B, Müller D, Veras Gimenez Fruchtengarten L, Hruby K, De Souza Nascimento E, Di Lorenzo C, Restani P, Kupferschmidt H, Ceschi A. Adverse Effects of Plant Food Supplements and Plants Consumed as Food: Results from the Poisons Centres-Based PlantLIBRA Study. Phytother Res 2016;30:988-96. [PMID: 26948409 DOI: 10.1002/ptr.5604] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
18 Becker MW, Schwambach KH, Lunardelli M, Blatt CR. Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence? World J Gastrointest Pharmacol Ther 2021;12:40-55. [PMID: 34046243 DOI: 10.4292/wjgpt.v12.i3.40] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 López-Riera M, Conde I, Quintas G, Pedrola L, Zaragoza Á, Perez-Rojas J, Salcedo M, Benlloch S, Castell JV, Jover R. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Sci Rep 2018;8:10606. [PMID: 30006517 DOI: 10.1038/s41598-018-28854-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
20 Teschke R, Eickhoff A, Wolff A, Xuan TD. Liver Injury from Herbs and “Dietary Supplements”: Highlights of a Literature Review from 2015 to 2017. Curr Pharmacol Rep 2018;4:120-31. [DOI: 10.1007/s40495-018-0124-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
21 Sarris J, Byrne GJ, Bousman CA, Cribb L, Savage KM, Holmes O, Murphy J, Macdonald P, Short A, Nazareth S, Jennings E, Thomas SR, Ogden E, Chamoli S, Scholey A, Stough C. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Aust N Z J Psychiatry 2020;54:288-97. [PMID: 31813230 DOI: 10.1177/0004867419891246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Peng Y, Wu Z, Yang H, Cai Y, Liu G, Li W, Tang Y. Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach. Toxicology Letters 2019;312:22-33. [DOI: 10.1016/j.toxlet.2019.05.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Maor Y, Ergaz D, Malnick SDH, Melzer E, Neuman MG. Liraglutide-Induced Hepatotoxicity. Biomedicines 2021;9:106. [PMID: 33498980 DOI: 10.3390/biomedicines9020106] [Reference Citation Analysis]
24 Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E. Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat. Int J Mol Sci 2016;17:580. [PMID: 27092496 DOI: 10.3390/ijms17040580] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
25 Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 56] [Article Influence: 40.5] [Reference Citation Analysis]
26 Zhang W, Chen L, Shen Y, Xu J. Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway. Toxicology in Vitro 2016;36:186-96. [DOI: 10.1016/j.tiv.2016.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
27 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
28 Nagral A, Adhyaru K, Rudra OS, Gharat A, Bhandare S. Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A case series. J Clin Exp Hepatol 2021. [PMID: 34230786 DOI: 10.1016/j.jceh.2021.06.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
29 Shamberg L, Vaziri H. Hepatotoxicity of Inflammatory Bowel Disease Medications. Journal of Clinical Gastroenterology 2018;52:674-84. [DOI: 10.1097/mcg.0000000000001084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang C, Wang N, Xu Y, Tan HY, Li S, Feng Y. Molecular Mechanisms Involved in Oxidative Stress-Associated Liver Injury Induced by Chinese Herbal Medicine: An Experimental Evidence-Based Literature Review and Network Pharmacology Study. Int J Mol Sci 2018;19:E2745. [PMID: 30217028 DOI: 10.3390/ijms19092745] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
31 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, Mazzucchelli L, Nofziger C, Paulmichl M, Vergani D. Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatol Commun 2017;1:293-8. [PMID: 29404460 DOI: 10.1002/hep4.1039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
32 Frenzel C, Teschke R. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int J Mol Sci. 2016;17:pii: E588. [PMID: 27128912 DOI: 10.3390/ijms17050588] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
33 Mehershahi S, Mantri N, Kumar A, Danial S, Harish P. Enoxaparin-Induced Liver Injury. Case Rep Gastroenterol 2020;14:315-9. [PMID: 32595436 DOI: 10.1159/000508471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
34 Abeles RD, Foxton M, Khan S, Goldin R, Smith B, Thursz MR, Verma S. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature. BMJ Open Gastroenterol 2020;7:e000549. [PMID: 33214235 DOI: 10.1136/bmjgast-2020-000549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhu J, Liu W, Zhang M, Lu L, Pan H, He X, Wang N, Yang M, Yi H, Tang S. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population. J Clin Pharm Ther 2021. [PMID: 34046917 DOI: 10.1111/jcpt.13452] [Reference Citation Analysis]
36 Zhu L, Zhang C, Zhang W, Xia Q, Ma J, He X, He Y, Fu PP, Jia W, Zhuge Y, Lin G. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human. Arch Toxicol 2021. [PMID: 34390356 DOI: 10.1007/s00204-021-03129-6] [Reference Citation Analysis]
37 Byeon JH, Kil JH, Ahn YC, Son CG. Systematic review of published data on herb induced liver injury. J Ethnopharmacol. 2019;233:190-196. [PMID: 30639232 DOI: 10.1016/j.jep.2019.01.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
38 He X, Wu Z, Wang L, Gao X, Hai Y, Liu W, Du L, Zhang L, Yang A, Huang N. An important mechanism of herb-induced hepatotoxicity: To produce RMs based on active functional groups-containing ingredients from phytomedicine by binding CYP450s. Chinese Herbal Medicines 2019;11:239-57. [DOI: 10.1016/j.chmed.2019.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Giacomelli A, Riva A, Falvella FS, Oreni ML, Cattaneo D, Cheli S, Renisi G, Di Cristo V, Lupo A, Clementi E, Rusconi S, Galli M, Ridolfo AL. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis 2018;18:556. [PMID: 30419834 DOI: 10.1186/s12879-018-3462-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
41 Kwon J, Kim S, Yoo H, Lee E. Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis. PLoS One 2019;14:e0209264. [PMID: 30677025 DOI: 10.1371/journal.pone.0209264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
42 Compaoré YD, Zongo I, Somé AF, Barry N, Nikiéma F, Kaboré TN, Ouattara A, Kabré Z, Wermi K, Zongo M, Yerbanga RS, Sagara I, Djimdé A, Ouédraogo JB. Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso. Malar J 2021;20:64. [PMID: 33514368 DOI: 10.1186/s12936-021-03593-6] [Reference Citation Analysis]
43 Teschke R. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 2018;6:E106. [PMID: 30424581 DOI: 10.3390/biomedicines6040106] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 15.3] [Reference Citation Analysis]
44 Kishimoto M, Adachi M, Takahashi K, Washizaki K. Clonazepam-induced liver dysfunction, severe hyperlipidaemia, and hyperglycaemic crisis: A case report. SAGE Open Med Case Rep 2019;7:2050313X19842976. [PMID: 31001426 DOI: 10.1177/2050313X19842976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Shahbaz O, Mahajan S, Lewis JH. Highlights of Drug - and Herb- induced liver injury in the Literature from 2016: How Best to Translate New Information into Clinical Practice? Expert Opin Drug Metab Toxicol. 2017;13:935-951. [PMID: 28772086 DOI: 10.1080/17425255.2017.1362391] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
46 Avigan MI, Muñoz MA. Perspectives on the Regulatory and Clinical Science of Drug-Induced Liver Injury (DILI). In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 367-93. [DOI: 10.1007/978-1-4939-7677-5_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, Xie Y. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021;21:100267. [PMID: 33053426 DOI: 10.1016/j.aohep.2020.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
48 Pedraza L, Laosa O, Rodríguez-Mañas L, Gutiérrez-Romero DF, Frías J, Carnicero JA, Ramírez E. Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method. Front Pharmacol 2020;11:600255. [PMID: 33613279 DOI: 10.3389/fphar.2020.600255] [Reference Citation Analysis]
49 Alfani R, Vassallo E, De Anseris AG, Nazzaro L, D'Acunzo I, Porfito C, Mandato C, Vajro P. Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. Children (Basel) 2018;5:E169. [PMID: 30551665 DOI: 10.3390/children5120169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
50 Huijbers A, Koggel LM, Bronkhorst C, Verheij J, Wanten GJA. Systematic Review: Noninvasive Assessments of Intestinal Failure–Associated Liver Disease in the Adult Population. Journal of Parenteral and Enteral Nutrition 2018;43:615-26. [DOI: 10.1002/jpen.1524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
51 Lin NH, Yang HW, Su YJ, Chang CW. Herb induced liver injury after using herbal medicine: A systemic review and case-control study. Medicine (Baltimore). 2019;98:e14992. [PMID: 30921214 DOI: 10.1097/md.0000000000014992] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
52 Yuan D, Yang X, Guo JC. A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine. J Zhejiang Univ Sci B 2016;17:405-8. [PMID: 27143269 DOI: 10.1631/jzus.B1600094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
53 Zhang Q, Li Y, Liu M, Duan J, Zhou X, Zhu H. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide. Int J Mol Sci 2018;19:E305. [PMID: 29351251 DOI: 10.3390/ijms19010305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
54 Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. Ann Hepatol 2017;16:818-21. [PMID: 28809737 DOI: 10.5604/01.3001.0010.2829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
56 Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report. World J Clin Cases 2018;6:1206-9. [PMID: 30613684 DOI: 10.12998/wjcc.v6.i16.1206] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 van Hunsel F, van de Koppel S, Skalli S, Kuemmerle A, Teng L, Wang JB, Barnes J. Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase. Front Pharmacol 2019;10:1326. [PMID: 31780942 DOI: 10.3389/fphar.2019.01326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Savage RL, Hill GR, Barnes J, Kenyon SH, Tatley MV. Suspected Hepatotoxicity With a Supercritical Carbon Dioxide Extract of Artemisia annua in Grapeseed Oil Used in New Zealand. Front Pharmacol 2019;10:1448. [PMID: 31920644 DOI: 10.3389/fphar.2019.01448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
59 Pai S, Njoku DB. The Role of Hypoxia-Induced Mitogenic Factor in Organ-Specific Inflammation in the Lung and Liver: Key Concepts and Gaps in Knowledge Regarding Molecular Mechanisms of Acute or Immune-Mediated Liver Injury. Int J Mol Sci 2021;22:2717. [PMID: 33800244 DOI: 10.3390/ijms22052717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zhu L, Chen X, Kong X, Cai YD. Investigation of the roles of trace elements during hepatitis C virus infection using protein-protein interactions and a shortest path algorithm. Biochim Biophys Acta 2016;1860:2756-68. [PMID: 27208424 DOI: 10.1016/j.bbagen.2016.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
61 Atallah E, Wijayasiri P, Cianci N, Abdullah K, Mukherjee A, Aithal GP. Zanubrutinib-induced liver injury: a case report and literature review. BMC Gastroenterol 2021;21:244. [PMID: 34051727 DOI: 10.1186/s12876-021-01825-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Reference Citation Analysis]
63 Mei X, Wu HC, Ruan M, Cai LR. Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report. World J Clin Cases 2021;9:4310-7. [PMID: 34141795 DOI: 10.12998/wjcc.v9.i17.4310] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. WJH 2021;13:1143-53. [DOI: 10.4254/wjh.v13.i9.1143] [Reference Citation Analysis]
65 Karousatos CM, Lee JK, Braxton DR, Fong TL. Case series and review of Ayurvedic medication induced liver injury. BMC Complement Med Ther 2021;21:91. [PMID: 33714265 DOI: 10.1186/s12906-021-03251-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
66 Lee MS, Lee JY, Kang MG, Jung JW, Park HK, Park HK, Kim SH, Lee EK. Cost implications of adverse drug event-related emergency department visits - a multicenter study in South Korea. Expert Rev Pharmacoecon Outcomes Res 2020;20:139-46. [PMID: 31012333 DOI: 10.1080/14737167.2019.1608825] [Reference Citation Analysis]
67 Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2017;13:425-438. [PMID: 27822971 DOI: 10.1080/17425255.2017.1252749] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
68 Kim JH, Choi WG, Lee S, Lee HS. Revisiting the Metabolism and Bioactivation of Ketoconazole in Human and Mouse Using Liquid Chromatography-Mass Spectrometry-Based Metabolomics. Int J Mol Sci 2017;18:E621. [PMID: 28335386 DOI: 10.3390/ijms18030621] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
69 Zhu Y, Niu M, Wang JB, Wang RL, Li JY, Ma YQ, Zhao YL, Zhang YF, He TT, Yu SM, Guo YM, Zhang F, Xiao XH, Schulze J. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk J Gastroenterol. 2019;30:47-58. [PMID: 30289391 DOI: 10.5152/tjg.2018.17847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
70 Ma J, Ruan J, Chen X, Li D, Yao S, Fu PP, Ye Y, Gao H, Wang J, Lin G. Pyrrole-Hemoglobin Adducts, a More Feasible Potential Biomarker of Pyrrolizidine Alkaloid Exposure. Chem Res Toxicol 2019;32:1027-39. [PMID: 31012303 DOI: 10.1021/acs.chemrestox.8b00369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
71 Wang Y, Wang L, Saxena R, Wee A, Yang R, Tian Q, Zhang J, Zhao X, Jia J. Clinicopathological features of He Shou Wu - induced liver injury: This ancient anti-aging therapy is not liver-friendly. Liver Int 2019;39:389-400. [DOI: 10.1111/liv.13939] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
72 Abbara A, Chitty S, Roe JK, Ghani R, Collin SM, Ritchie A, Kon OM, Dzvova J, Davidson H, Edwards TE, Hateley C, Routledge M, Buckley J, Davidson RN, John L. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC Infect Dis 2017;17:231. [PMID: 28340562 DOI: 10.1186/s12879-017-2330-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
73 Yang L, Shou Y, Li F, Zhu X, Yang Y, Xu J. Retrospective study of 213 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis from China. Burns 2020;46:959-69. [DOI: 10.1016/j.burns.2019.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
74 Shao YM, Zhang Y, Yin X, Qin TT, Jin QL, Wen XY. Herb-induced autoimmune-like hepatitis associated with Xiang-tian-guo (Swietenia macrophylla seeds): A case report and literature review. Medicine (Baltimore) 2021;100:e24045. [PMID: 33466156 DOI: 10.1097/MD.0000000000024045] [Reference Citation Analysis]
75 Kim JH, Nam WS, Kim SJ, Kwon OK, Seung EJ, Jo JJ, Shresha R, Lee TH, Jeon TW, Ki SH, Lee HS, Lee S. Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice. Int J Mol Sci 2017;18:E1417. [PMID: 28671602 DOI: 10.3390/ijms18071417] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
76 Kulkarni AV, Kumar P, Talukdar R, Rao NP. Steroids as rescue therapy for vitamin A-induced acute liver failure. BMJ Case Rep 2020;13:e233902. [PMID: 32139453 DOI: 10.1136/bcr-2019-233902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Praharaj DL, Mallick B, Nath P, Panigrahi SC, Padhan P, Sahu N. Unusual Presentation of Systemic Lupus Erythematosus in a Young Male: A Case Report. J Clin Exp Hepatol 2021;11:264-9. [PMID: 33746453 DOI: 10.1016/j.jceh.2020.05.009] [Reference Citation Analysis]
78 Ma S, Liu S, Wang Q, Chen L, Yang P, Sun H. Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database. J Clin Pharm Ther 2020;45:204-7. [PMID: 31518450 DOI: 10.1111/jcpt.13042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
79 Malhotra K, Fazylov R, Friedman-Jakubovics M. A Case-Report of Drug-Induced Mixed Liver Injury Resulting From Cefepime Exposure. J Pharm Pract 2021;:8971900211015046. [PMID: 34098807 DOI: 10.1177/08971900211015046] [Reference Citation Analysis]
80 Falcão D, Pedroto I, Moreira T. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series. Dig Liver Dis 2021:S1590-8658(21)00372-8. [PMID: 34376370 DOI: 10.1016/j.dld.2021.07.003] [Reference Citation Analysis]
81 Yang H, Guo D, Xu Y, Zhu M, Yao C, Chen C, Jia W. Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods. Front Pharmacol 2019;10:816. [PMID: 31379581 DOI: 10.3389/fphar.2019.00816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
82 Quan NV, Dang Xuan T, Teschke R. Potential Hepatotoxins Found in Herbal Medicinal Products: A Systematic Review. Int J Mol Sci 2020;21:E5011. [PMID: 32708570 DOI: 10.3390/ijms21145011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
83 Tao B, Yang M, Chen H, Pan H, Liu W, Yi H, Tang S. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population. J Clin Pharm Ther 2020;45:638-45. [PMID: 32259340 DOI: 10.1111/jcpt.13139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
84 Thomsen M, Schmidt M. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. J Ethnopharmacol 2021;268:113582. [PMID: 33189846 DOI: 10.1016/j.jep.2020.113582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
85 Raschi E, De Ponti F. Drug-induced liver injury: Towards early prediction and risk stratification. World J Hepatol 2017;9:30-7. [PMID: 28105256 DOI: 10.4254/wjh.v9.i1.30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
86 Li XL, Liu XC, Song YL, Hong RT, Shi H. Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature. BMC Gastroenterol 2018;18:130. [PMID: 30143001 DOI: 10.1186/s12876-018-0858-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
87 Gao Y, Wang Z, Tang J, Liu X, Shi W, Qin N, Wang X, Pang Y, Li R, Zhang Y, Wang J, Niu M, Bai Z, Xiao X. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions. Front Med 2020;14:68-80. [PMID: 30924023 DOI: 10.1007/s11684-019-0690-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
88 Laube R, Liu K. An unwanted complement: Rare case of potential liver injury induced by an interaction between ginseng and atorvastatin. Br J Clin Pharmacol 2019;85:1612-3. [PMID: 30980549 DOI: 10.1111/bcp.13927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
89 Avila C, Breakspear I, Hawrelak J, Salmond S, Evans S. A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale). Fitoterapia 2020;142:104519. [PMID: 32105669 DOI: 10.1016/j.fitote.2020.104519] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
90 Chayanupatkul M, Schiano TD. Acute Liver Failure Secondary to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:75-87. [PMID: 31753252 DOI: 10.1016/j.cld.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
91 Teschke R, Danan G. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies. Int J Mol Sci 2021;22:3441. [PMID: 33810530 DOI: 10.3390/ijms22073441] [Reference Citation Analysis]
92 Wang R, Qi X, Yoshida EM, Méndez-sánchez N, Teschke R, Sun M, Liu X, Su C, Deng J, Deng H, Hou F, Guo X. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review. Expert Review of Gastroenterology & Hepatology 2018;12:425-34. [DOI: 10.1080/17474124.2018.1427581] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
93 Schimmel J, Dart RC. Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review.Drugs. 2020;80:263-283. [PMID: 31919755 DOI: 10.1007/s40265-019-01242-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
94 Vincenzi B, Russo A, Terenzio A, Galvano A, Santini D, Vorini F, Antonelli-Incalzi R, Vespasiani-Gentilucci U, Tonini G. The use of SAMe in chemotherapy-induced liver injury. Crit Rev Oncol Hematol 2018;130:70-7. [PMID: 30196914 DOI: 10.1016/j.critrevonc.2018.06.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
95 Alqrinawi SH, Akbar N, AlFaddag H, Akbar S, Akbar L, Butt SA, Aljawad M. Menotrophin Induced Autoimmune Hepatitis. Case Rep Gastrointest Med 2019;2019:7343805. [PMID: 31565446 DOI: 10.1155/2019/7343805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Umbaugh DS, Jaeschke H. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity. Expert Rev Gastroenterol Hepatol 2021;15:363-75. [PMID: 33242385 DOI: 10.1080/17474124.2021.1857238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Vliegenthart ADB, Berends C, Potter CMJ, Kersaudy-Kerhoas M, Dear JW. MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol 2017;83:2027-33. [PMID: 28257154 DOI: 10.1111/bcp.13282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
99 Nhean S, Yoong D, Wong DK, Gough K, Tseng AL. Probable hepatotoxicity with dolutegravir: report of two cases and review of the literature. AIDS 2019;33:1261-3. [PMID: 31045944 DOI: 10.1097/QAD.0000000000002191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
100 Lombardi N, Crescioli G, Maggini V, Ippoliti I, Menniti-Ippolito F, Gallo E, Brilli V, Lanzi C, Mannaioni G, Firenzuoli F, Vannacci A. Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports. Br J Clin Pharmacol 2021;87:741-53. [PMID: 32656820 DOI: 10.1111/bcp.14460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
101 Dinis-Oliveira RJ, Vieira DN. Acute liver failure requiring transplantation: A possible link to ulipristal acetate treatment? Basic Clin Pharmacol Toxicol 2021;129:278-82. [PMID: 34187080 DOI: 10.1111/bcpt.13631] [Reference Citation Analysis]
102 Hiraki M, Tanaka T, Koga F, Saito A, Oza N, Ikeda O, Manabe T, Miyoshi A, Kitahara K, Sato S, Noshiro H. An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report. J Gastrointest Cancer 2020;51:296-9. [PMID: 30903577 DOI: 10.1007/s12029-019-00228-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
103 Shehu AI, Ma X, Venkataramanan R. Mechanisms of Drug-Induced Hepatotoxicity. Clin Liver Dis. 2017;21:35-54. [PMID: 27842774 DOI: 10.1016/j.cld.2016.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
104 Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. Front Pharmacol. 2019;10:853. [PMID: 31417407 DOI: 10.3389/fphar.2019.00853] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
105 Zhang P, Ye Y, Yang X, Jiao Y. Systematic Review on Chinese Herbal Medicine Induced Liver Injury. Evid Based Complement Alternat Med. 2016;2016:3560812. [PMID: 27651817 DOI: 10.1155/2016/3560812] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
106 Teschke R. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opin Pharmacother 2018;19:779-93. [PMID: 29708448 DOI: 10.1080/14656566.2018.1465929] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
107 Chen Y, Wang C, Yang H, Huang P, Shi J, Tong Y, Jiang J, Zhang X, Chen W, Xuan Z. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. Biomed Res Int 2021;2021:8894498. [PMID: 33954202 DOI: 10.1155/2021/8894498] [Reference Citation Analysis]
108 Vickers AE, Ulyanov AV, Fisher RL. Liver Effects of Clinical Drugs Differentiated in Human Liver Slices. Int J Mol Sci 2017;18:E574. [PMID: 28272341 DOI: 10.3390/ijms18030574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
109 Funakoshi H, Momo K, Kashima A, Ida H, Miyata Y, Sagara H, Sasaki T. Liver Injury by the Traditional Chinese Medicine Hanshirento, Zenshikunshito, and Ninjin'yoeito in a Patient with Lung Cancer: Probable Causality Assessed by the Updated Roussel Uclaf Causality Assessment Method. Integr Cancer Ther 2021;20:15347354211004734. [PMID: 33769124 DOI: 10.1177/15347354211004734] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Brar HS, Marathi R. Case of cholestatic drug-induced liver injury (DILI) associated with black cohosh. BMJ Case Rep 2021;14:e240408. [PMID: 33962922 DOI: 10.1136/bcr-2020-240408] [Reference Citation Analysis]
111 Xia C, Liu Y, Yao H, Zhu W, Ding J, Jin J. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature. J Int Med Res 2020;48:300060520917569. [PMID: 32293220 DOI: 10.1177/0300060520917569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
113 Duzenli T, Tanoglu A, Akyol T, Kara M, Yazgan Y. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol 2019;9:49-51. [PMID: 31988867 DOI: 10.5005/jp-journals-10018-1295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Antony A, Lee TP. Herb-Induced Liver Injury With Cholestasis and Renal Injury Secondary to Short-Term Use of Kratom (Mitragyna speciosa). Am J Ther 2019;26:e546-7. [PMID: 29927773 DOI: 10.1097/MJT.0000000000000802] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
115 Teschke R, Danan G. Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease. Drug Saf. 2016;39:729-744. [PMID: 27091053 DOI: 10.1007/s40264-016-0423-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
116 Li C, He Q, Gao D, Li R, Zhu Y, Li H, Feng W, Yang M, Xiao X, Wang J. Idiosyncratic drug-induced liver injury linked to Polygonum multiflorum: A case study by pharmacognosy. Chin J Integr Med 2017;23:625-30. [DOI: 10.1007/s11655-017-2543-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
117 Unger C, Al-Jashaami LS. Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation. Am J Case Rep 2016;17:676-81. [PMID: 27653941 DOI: 10.12659/ajcr.899080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
118 Papafragkakis C, Ona MA, Reddy M, Anand S. Acute Hepatitis after Ingestion of a Preparation of Chinese Skullcap and Black Catechu for Joint Pain. Case Reports Hepatol. 2016;2016:4356749. [PMID: 27144042 DOI: 10.1155/2016/4356749] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
119 Yousaf MN, Chaudhary FS, Hodanazari SM, Sittambalam CD. Hepatotoxicity associated with Garcinia cambogia: A case report. World J Hepatol. 2019;11:735-742. [PMID: 31772720 DOI: 10.4254/wjh.v11.i11.735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
120 Riebensahm C, Ka D, Sow A, Semmo N, Wandeler G. A closer look at the spectrum of drug-induced liver injury in sub-Saharan Africa. Expert Rev Clin Pharmacol 2019;12:875-83. [PMID: 31269818 DOI: 10.1080/17512433.2019.1638251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Watkins PB. Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications. Adv Pharmacol 2019;85:165-93. [PMID: 31307586 DOI: 10.1016/bs.apha.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
122 Li DK, Chen J, Ge ZZ, Sun ZX. Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1. Evid Based Complement Alternat Med 2017;2017:9456785. [PMID: 28626488 DOI: 10.1155/2017/9456785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
123 Fu B, Wang N, Tan HY, Li S, Cheung F, Feng Y. Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences. Front Pharmacol 2018;9:1394. [PMID: 30555327 DOI: 10.3389/fphar.2018.01394] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 12.7] [Reference Citation Analysis]
124 Colaci CS, Mendizabal M, Bessone F. Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing Scenario. Curr Drug Saf 2019;14:94-101. [PMID: 30767751 DOI: 10.2174/1574886314666190215115434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
125 Willson C. Sympathomimetic amine compounds and hepatotoxicity: Not all are alike-Key distinctions noted in a short review. Toxicol Rep 2019;6:26-33. [PMID: 30581759 DOI: 10.1016/j.toxrep.2018.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Sobhonslidsuk A, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Phaosawasdi K. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study. BMC Gastroenterol 2016;16:135. [PMID: 27793116 DOI: 10.1186/s12876-016-0550-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
127 López-Gil S, Nuño-Lámbarri N, Chávez-Tapia N, Uribe M, Barbero-Becerra VJ. Liver toxicity mechanisms of herbs commonly used in Latin America. Drug Metab Rev 2017;49:338-56. [PMID: 28571502 DOI: 10.1080/03602532.2017.1335750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
128 Ostrovsky V, Malnick S, Ish-Shalom S, Ziv Sokolowskaia N, Yosepovich A, Neuman M. Denosumab-Induced Immune Hepatitis. Biomedicines 2021;9:76. [PMID: 33466886 DOI: 10.3390/biomedicines9010076] [Reference Citation Analysis]
129 Lee J, Shin J, Lee YJ, Kim M, Shin B, Lee J, Lee MS, Ha I. Battle Over Herb-Induced Liver Injury: Low Prevalence Confirmed through Secondary Evaluation and Research Team's Clarifying Rebuttal to Unwarranted Public Claims. The Journal of Alternative and Complementary Medicine 2019;25:260-4. [DOI: 10.1089/acm.2018.0253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
130 Teschke R, Wolff A, Eickhoff A, Danan G. Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury? JGH Open 2018;2:152-7. [PMID: 30483581 DOI: 10.1002/jgh3.12057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
131 Brewer CT, Chen T. Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450. Int J Mol Sci 2017;18:E2353. [PMID: 29117101 DOI: 10.3390/ijms18112353] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 9.8] [Reference Citation Analysis]
132 Li D, Yang M, Zuo Z. Overview of Pharmacokinetics and Liver Toxicities of Radix Polygoni Multiflori.Toxins (Basel). 2020;12. [PMID: 33233441 DOI: 10.3390/toxins12110729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Teschke R. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Front Pharmacol 2019;10:730. [PMID: 31396080 DOI: 10.3389/fphar.2019.00730] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
134 Fateh AH, Mohamed Z, Chik Z, Alsalahi A, Md Zain SR, Alshawsh MA. Mutagenicity and genotoxicity effects of Verbena officinalis leaves extract in Sprague-Dawley Rats. J Ethnopharmacol 2019;235:88-99. [PMID: 30738113 DOI: 10.1016/j.jep.2019.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
135 Liu Z, He X, Wang L, Zhang Y, Hai Y, Gao R. Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Database. Curr Drug Metab 2019;20:138-46. [PMID: 30101702 DOI: 10.2174/1389200219666180813144114] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
136 Gharia B, Seegobin K, Maharaj S, Marji N, Deutch A, Zuberi L. Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature. Oxf Med Case Reports 2017;2017:omx074. [PMID: 29230302 DOI: 10.1093/omcr/omx074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
137 Liu Y, Wang W, Sun M, Ma B, Pang L, Du Y, Dong X, Yin X, Ni J. Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges. Front Pharmacol 2019;10:1467. [PMID: 31920657 DOI: 10.3389/fphar.2019.01467] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
138 Shumar J, Ordway S, Junga Z, Sadowski B, Torres D. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM). ACG Case Rep J 2019;6:e00184. [PMID: 31737715 DOI: 10.14309/crj.0000000000000184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
139 Han B, Yang Y, Tang L, Yang Q, Xie R. Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis. J Clin Transl Hepatol 2021;9:364-72. [PMID: 34221922 DOI: 10.14218/JCTH.2020.00185] [Reference Citation Analysis]
140 Svedlund E, Larsson M, Hägerkvist R. Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007-15: Report from the Medical Products Agency. Drugs Real World Outcomes 2017;4:119-25. [PMID: 28353157 DOI: 10.1007/s40801-017-0104-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Pholmoo N, Bunchorntavakul C. Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand. J Clin Transl Hepatol 2019;7:132-9. [PMID: 31293913 DOI: 10.14218/JCTH.2018.00066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Abbass A, Khalid S, Farooq U, Rakov N, Hanson J, Martin D, McCarthy D. If DILI Is Suspected, Don't Dally. Dig Dis Sci 2021;66:52-5. [PMID: 33398719 DOI: 10.1007/s10620-020-06730-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Teschke R, Eickhoff A. Suspected Liver Injury and the Dilemma of Causality. Dig Dis Sci. 2017;62:1095-1098. [PMID: 28210906 DOI: 10.1007/s10620-016-4442-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
144 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 129] [Article Influence: 99.0] [Reference Citation Analysis]
145 Iorga A, Dara L, Kaplowitz N. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. Int J Mol Sci. 2017;18. [PMID: 28486401 DOI: 10.3390/ijms18051018] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 27.0] [Reference Citation Analysis]
146 Imam Z, Khasawneh M, Jomaa D, Iftikhar H, Sayedahmad Z. Drug Induced Liver Injury Attributed to a Curcumin Supplement. Case Rep Gastrointest Med. 2019;2019:6029403. [PMID: 31781418 DOI: 10.1155/2019/6029403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
147 Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases 2019;7:E27. [PMID: 30823570 DOI: 10.3390/diseases7010027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
148 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
149 Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol 2016;15:91-109. [PMID: 26626645 DOI: 10.5604/16652681.1184237] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
150 Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, Giancaspro GI, Navarro V, Paine MF, Betz JM, Marles RJ, Casper S, Gurley B, Jordan SA, He K, Kapoor MP, Rao TP, Sherker AH, Fontana RJ, Rossi S, Vuppalanchi R, Seeff LB, Stolz A, Ahmad J, Koh C, Serrano J, Low Dog T, Ko R. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020;7:386-402. [PMID: 32140423 DOI: 10.1016/j.toxrep.2020.02.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 33.0] [Reference Citation Analysis]
151 Mullins C, Beaulac K, Sylvia L. Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment. Ann Pharmacother 2020;54:526-32. [PMID: 31786964 DOI: 10.1177/1060028019892587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
152 Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
153 Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H;  Drug-induced Liver Injury (DILI) Study Group;  Chinese Society of Hepatology (CSH);  Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221-241. [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 23.0] [Reference Citation Analysis]
154 Scalfaro E, Streefkerk HJ, Merz M, Meier C, Lewis D. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM. Drug Saf 2017;40:715-27. [PMID: 28508325 DOI: 10.1007/s40264-017-0541-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
155 O'Reilly M, Mellotte G, Ryan B, O'Connor A. Gastrointestinal side effects of cancer treatments. Ther Adv Chronic Dis 2020;11:2040622320970354. [PMID: 33294145 DOI: 10.1177/2040622320970354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
156 Tillmann HL, Suzuki A, Barnhart HX, Serrano J, Rockey DC. Tools for causality assessment in drug-induced liver disease. Curr Opin Gastroenterol 2019;35:183-90. [PMID: 30865042 DOI: 10.1097/MOG.0000000000000526] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
157 Lee SH, Kim SY, Yang SB, Jin C, Kwon S, Cho SY, Park SU, Jung WS, Moon SK, Park JM, Ko CN. Safety of co-administration of herbal and conventional medicines on liver and kidney function in stroke patients: A single-center retrospective study. Phytomedicine 2021;81:153435. [PMID: 33338904 DOI: 10.1016/j.phymed.2020.153435] [Reference Citation Analysis]
158 Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol 2018;84:1467-77. [PMID: 29607530 DOI: 10.1111/bcp.13593] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
159 Yan Y, Wang K, Tang X, Gao JF, Wen BY. Phytochemicals protect L02 cells against hepatotoxicity induced by emodin via the Nrf2 signaling pathway. Toxicol Res (Camb) 2019;8:1028-34. [PMID: 32153769 DOI: 10.1039/c9tx00220k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Teschke R, Andrade RJ. Drug, Herb, and Dietary Supplement Hepatotoxicity. Int J Mol Sci 2016;17:E1488. [PMID: 27608014 DOI: 10.3390/ijms17091488] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
161 Liu R, Li X, Huang N, Fan M, Sun R. Toxicity of traditional Chinese medicine herbal and mineral products. Adv Pharmacol 2020;87:301-46. [PMID: 32089237 DOI: 10.1016/bs.apha.2019.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
162 Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol 2017;9:1141-57. [PMID: 29085558 DOI: 10.4254/wjh.v9.i29.1141] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
163 Teschke R, Eickhoff A. The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges. Int J Mol Sci. 2016;17:476. [PMID: 27043544 DOI: 10.3390/ijms17040476] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
164 Liu J, Dai XL, Zhou XJ, Gu BH, Yang ZH, Lai J. Metamizole-induced acute liver failure in a boy. Clin Res Hepatol Gastroenterol 2021;45:101570. [PMID: 33303406 DOI: 10.1016/j.clinre.2020.11.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Peeraphatdit TB, Wang J, Odenwald MA, Hu S, Hart J, Charlton MR. Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation. Hepatology. 2020;72:315-329. [PMID: 32167613 DOI: 10.1002/hep.31227] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 33.0] [Reference Citation Analysis]
166 Awortwe C, Makiwane M, Reuter H, Muller C, Louw J, Rosenkranz B. Critical evaluation of causality assessment of herb-drug interactions in patients. Br J Clin Pharmacol 2018;84:679-93. [PMID: 29363155 DOI: 10.1111/bcp.13490] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 18.7] [Reference Citation Analysis]
167 Teschke R, Danan G. Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A report of Excellence. Ann Hepatol 2017;16:324-5. [PMID: 28425398 DOI: 10.5604/16652681.1235471] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
168 Patel R, Alavi F, Ortega S, Matela A. Herb-Induced Liver Injury by Cimicifuga racemosa and Thuja occidentalis Herbal Medications for Fertility. Case Rep Gastrointest Med 2021;2021:8858310. [PMID: 33532101 DOI: 10.1155/2021/8858310] [Reference Citation Analysis]
169 Grievink HW, Heuberger JAAC, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR, Mosesova S, Erickson R, Moerland M, Haddick PCG, Scearce-Levie K, Ho C, Groeneveld GJ. DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. Clin Pharmacol Ther 2020;107:406-14. [PMID: 31437302 DOI: 10.1002/cpt.1615] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
170 Dragoi D, Benesic A, Pichler G, Kulak NA, Bartsch HS, Gerbes AL. Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac. Front Pharmacol 2018;9:699. [PMID: 30022949 DOI: 10.3389/fphar.2018.00699] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
171 Chow HC, So TH, Choi HCW, Lam KO. Literature Review of Traditional Chinese Medicine Herbs-Induced Liver Injury From an Oncological Perspective With RUCAM. Integr Cancer Ther 2019;18:1534735419869479. [PMID: 31405304 DOI: 10.1177/1534735419869479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
172 Zhang F, Zhou Y, Yang X, Xiong AZ, Wang ZT, Yang L. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors. Acta Pharmacol Sin 2019;40:781-9. [PMID: 30367152 DOI: 10.1038/s41401-018-0155-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
173 Liao PF, Wu YK, Huang KL, Chen HY. A rare case of cefepime-induced cholestatic liver injury. Ci Ji Yi Xue Za Zhi 2019;31:124-8. [PMID: 31007494 DOI: 10.4103/tcmj.tcmj_151_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
174 Hayashi M, Abe K, Fujita M, Takahashi A, Kobayashi Y, Hashimoto Y, Ohira H. Pazopanib-induced mixed liver injury in a patient with soft-tissue sarcoma, but without the UGT1A1*28 mutation: a case report. Clin J Gastroenterol 2021;14:224-8. [PMID: 32990937 DOI: 10.1007/s12328-020-01253-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Teschke R, Uetrecht J. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. Ann Transl Med 2021;9:730. [PMID: 33987428 DOI: 10.21037/atm-2020-ubih-05] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Becker MW, Lourençone EMS, De Mello AF, Branco A, Filho EMR, Blatt CR, Mallmann CA, Schneider M, Caregnato RCA, Blatt CR. Liver transplantation and the use of KAVA: Case report. Phytomedicine 2019;56:21-6. [PMID: 30668342 DOI: 10.1016/j.phymed.2018.08.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
177 Lin L, Li H, Lin H, Zhang M, Qu C, Yan L, Yin X, Ni J. A New Perspective on Liver Injury by Traditional Chinese Herbs Such As Polygonum multiflorum: The Geographical Area of Harvest As an Important Contributory Factor. Front Pharmacol 2017;8:349. [PMID: 28676759 DOI: 10.3389/fphar.2017.00349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
178 Meunier L, Larrey D. Recent Advances in Hepatotoxicity of Non Steroidal Anti-inflammatory Drugs. Annals of Hepatology 2018;17:187-91. [DOI: 10.5604/01.3001.0010.8633] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
179 Jing J, Teschke R. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. J Clin Transl Hepatol 2018;6:57-68. [PMID: 29577033 DOI: 10.14218/JCTH.2017.00033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
180 Xiao X, Tang J, Mao Y, Li X, Wang J, Liu C, Sun K, Ye Y, Zou Z, Peng C, Yang L, Guo Y, Bai Z, He T, Jing J, Li F, An N. Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration. Acta Pharm Sin B 2019;9:648-58. [PMID: 31193760 DOI: 10.1016/j.apsb.2018.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
181 Barcelos STA, Dall'Oglio VM, de Araújo A, Cerski CTS, Álvares-da-Silva MR. Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report. Ann Hepatol 2021;20:100138. [PMID: 31606353 DOI: 10.1016/j.aohep.2019.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
182 Kesavarapu K, Kang M, Shin JJ, Rothstein K. Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case Rep Gastrointest Med. 2017;2017:3540756. [PMID: 29204300 DOI: 10.1155/2017/3540756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
183 Kothadia JP, Kaminski M, Samant H, Olivera-Martinez M. Hepatotoxicity Associated with Use of the Weight Loss Supplement Garcinia cambogia: A Case Report and Review of the Literature. Case Reports Hepatol. 2018;2018:6483605. [PMID: 29721342 DOI: 10.1155/2018/6483605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
184 Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
185 Lammel-Lindemann JA, Flores-Villalba E, Martagón AJ, DeObeso-Gonzalez E, Puente-Gallegos F. Noncholestatic acute hepatocellular injury following candesartan administration. Br J Clin Pharmacol 2018;84:204-7. [PMID: 28841231 DOI: 10.1111/bcp.13406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
186 Real M, Barnhill MS, Higley C, Rosenberg J, Lewis JH. Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug Saf 2019;42:365-87. [PMID: 30343418 DOI: 10.1007/s40264-018-0743-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
187 Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci. 2017;18:E803. [PMID: 28398242 DOI: 10.3390/ijms18040803] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
188 Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017;66:1154-64. [PMID: 28341748 DOI: 10.1136/gutjnl-2016-313369] [Cited by in Crossref: 196] [Cited by in F6Publishing: 143] [Article Influence: 49.0] [Reference Citation Analysis]
189 Suh Y, Ah YM, Chun HJ, Lee SM, Kim HS, Gu HJ, Kim AJ, Chung JE, Cho Y, Lee YH, Hwangbo SY, Kim J, Kim ES, Kim HB, Lee E, Lee JY. Potential Impact of the Involvement of Clinical Pharmacists in Antimicrobial Stewardship Programs on the Incidence of Antimicrobial-Related Adverse Events in Hospitalized Patients: A Multicenter Retrospective Study. Antibiotics (Basel) 2021;10:853. [PMID: 34356774 DOI: 10.3390/antibiotics10070853] [Reference Citation Analysis]
190 Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
191 Hunt CM. Expanding our toolkit to better identify drug-induced liver injury in electronic medical records. Liver Int 2018;38:585-7. [PMID: 29575769 DOI: 10.1111/liv.13710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
192 Wu Y, Geng XC, Wang JF, Miao YF, Lu YL, Li B. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury. Cell Biol Toxicol 2016;32:37-59. [PMID: 27027780 DOI: 10.1007/s10565-016-9316-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
193 McEuen K, Borlak J, Tong W, Chen M. Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.Int J Mol Sci. 2017;18. [PMID: 28640208 DOI: 10.3390/ijms18071335] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
194 Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Drug Saf. 2018;41:735-743. [PMID: 29502198 DOI: 10.1007/s40264-018-0654-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 14.7] [Reference Citation Analysis]
195 Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18. [PMID: 28930128 DOI: 10.3390/medicines3030018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
196 Han Y, Zhuang Y, Tang W, Chen L, Chen Y, Gong Q, Zhang X. Congenital dyserythropoietic anemia and drug-induced liver injury present as bland cholestasis: A case report. Exp Ther Med 2021;21:456. [PMID: 33777192 DOI: 10.3892/etm.2021.9887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Björnsson ES. Hepatotoxicity by Drugs: The Most Common Implicated Agents. Int J Mol Sci. 2016;17:224. [PMID: 26861310 DOI: 10.3390/ijms17020224] [Cited by in Crossref: 101] [Cited by in F6Publishing: 76] [Article Influence: 20.2] [Reference Citation Analysis]
198 Sandhu N, Navarro V. Drug-Induced Liver Injury in GI Practice. Hepatol Commun. 2020;4:631-645. [PMID: 32363315 DOI: 10.1002/hep4.1503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]